Silvia Pieralice

Silvia Pieralice received the graduate degree in medicine and surgery with Sapienza University, Rome, in 2016, and the degree (cum laude) in endocrinology and metabolic disorders from University Campus Bio-Medico di Roma, in 2019, where she is currently pursuing the Ph.D. degree in integrated biomedical sciences and bioethics with a research project entitled “Novel technologies to improve diabetes care and management.” Currently, she works as a Consultant Endocrinologist with University Campus Bio-Medico di Roma. She has acted as study sub investigator in national and international clinical trials and has published in top-ranked peer-reviewed international medical journal. Her main research interests include advanced technologies and novel therapies for type 2 (T2D) and type 1 diabetes (T1D) from basic studies to clinical trials testing novel therapies to prevent beta-cell destruction in patients affected by autoimmune diabetes.